Advansix Inc. (ASIX) Stock Price & Analysis
Advansix Inc. (ASIX) fell 1.59% to USD 21.05 as of July 25, 2026 at 04:19 UTC, according to Nexqual real-time market data.
ASIX last closed at USD 21.39; the session ranged USD 20.82–21.34 on volume of 112,095 shares. Market capitalization is $567.49M, with a 52-week range of USD 14.1–26.73 (NYQ). Source: Nexqual, July 25, 2026 at 04:19 UTC.
Key Statistics (as of July 25, 2026 at 04:19 UTC)
| Price | USD 21.05 |
|---|---|
| Change | ▼ 1.59% (down) |
| Previous Close | USD 21.39 |
| Open | USD 21.37 |
| Day Range | USD 20.82 – 21.34 |
| 52-Week Range | USD 14.1 – 26.73 |
| Volume | 112,095 shares |
| Market Cap | $567.49M |
| Exchange | NYQ |
Technical Analysis (ASIX)
Nexqual's technical model rates ASIX "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 04:19 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.86 (neutral) |
| vs SMA50 | Below (USD 21.19) |
| MACD | 0.06 (positive) |
Analyst Ratings (ASIX)
Wall Street analysts rate ASIX "None" based on 2 analysts, with a mean price target of USD 23.5 (range USD 20–27), per Nexqual as of July 25, 2026 at 04:19 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 23.5 |
| High Target | USD 27 |
| Low Target | USD 20 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (ASIX)
| Next Earnings Date | 2026-08-07 |
|---|---|
| EPS Estimate | USD 0.56 |
| Revenue Estimate | $452.15M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.5 vs est -0.48 ▼ miss |
| 2025-12-31 | USD 0.03 vs est -0.06 ▲ beat |
| 2025-09-30 | USD 0.08 vs est 0.4 ▼ miss |
Source: Nexqual, July 25, 2026 at 04:19 UTC.
Financials & Fundamentals (ASIX)
| Total Revenue | $1.55B |
|---|---|
| Revenue Growth (YoY) | +7.00% |
| Gross Margin | +9.12% |
| Operating Margin | -4.63% |
| Profit Margin | +0.67% |
| ROE | +1.31% |
| Debt / Equity | 53.54 |
| Current Ratio | 1.23 |
| Total Cash | $17.57M |
| Total Debt | $426.36M |
| Free Cash Flow | $-22.49M |
Source: Nexqual, July 25, 2026 at 04:19 UTC.
Financial Health Score (ASIX)
Nexqual rates Advansix Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 04:19 UTC.
| Growth | Mixed — Revenue +0.3% YoY (annual), slow |
|---|---|
| Profitability | Critical — Gross margin 9%, operating -5% |
| Balance Sheet | Solid — $18M cash vs $426M debt |
| Cash Flow | Weak — FCF negative: -$22M, burning cash |
| Efficiency | Weak — ROE 1%, ROA 1.4% |
Ownership (ASIX)
| Insider Ownership | +3.15% |
|---|---|
| Institutional Ownership | +93.65% |
| Shares Outstanding | 26.96M |
| Float | 24.39M |
| Short % of Float | +2.75% |
Source: Nexqual, July 25, 2026 at 04:19 UTC.
Leadership (ASIX)
Advansix Inc. is led by Erin N. Kane (age 48), CEO, President & Director, per Nexqual as of July 25, 2026 at 04:19 UTC.
| CEO, President & Director | Erin N. Kane (age 48) |
|---|---|
| Vice President of Corporate Finance, Strategic Financial Planning & Analysis | Christopher Gramm (age 55) |
| Senior VP & CFO | Patrick C. Day |
| Vice President, Controller, & Chief Accounting Officer | Rachael E. Ryan (age 41) |
Major Backers & Investors (ASIX)
Notable institutional backers of Advansix Inc. include American Century Companies Inc, Aegis Financial Corporation, Aegis Funds-Aegis Value Fund, according to Nexqual as of July 25, 2026 at 04:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century Companies Inc | 8.57% |
| Aegis Financial Corporation | 4.49% |
| Aegis Funds-Aegis Value Fund | 4.36% |
| Alliancebernstein L.P. | 3.23% |
| Arrowstreet Capital, Limited Partnership | 2.7% |
| Charles Schwab Investment Management, Inc. | 2.58% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 11.68% |
| Vanguard Group | 8.24% |
| Dimensional Fund Advisors | 4.86% |
| Geode Capital | 2.42% |
Source: Nexqual, July 25, 2026 at 04:19 UTC.
From Advansix Inc.'s Latest SEC 10-K Filing (filed 2026-02-20)
Key Strengths & Strategy (as disclosed to the SEC)
- In addition, we strive to understand the product applications and end markets into which our products are sold, which helps us upgrade the quality, chemical properties and packaging of our products to enable us to attract price premiums and greater demand. 2 AdvanSix serves approximately 375 customers annually, primarily in the United States, with global capabilities, spanning a wide variety of industries.
- Our vertically integrated manufacturing facilities, scale, access to lower cost raw materials, and high plant utilization rates help us maintain our position as the world's lowest cost producer of caprolactam.
- First, we are vertically integrated into several key feedstock materials necessary to produce caprolactam, particularly phenol, ammonia and oleum/sulfuric acid, which we believe is a unique advantage in our industry.
- Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| REZI | Resideo Technologies, Inc. | USD 34.54 | ▲ 1.32% |
| GTX | Garrett Motion Inc. | USD 31.51 | ▼ 1.13% |
| NGVT | Ingevity Corporation | USD 73.26 | ▼ 1.93% |
| ARCB | ArcBest Corporation | USD 154.3 | ▼ 3.19% |
| OEC | Orion S.A. | USD 6.99 | ▼ 7.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:19 UTC. This page is informational and not investment advice.